Skip to content

Trial of Prehabilitation in Vulnerable Patients Undergoing Cystectomy for Bladder Cancer

Trial of Prehabilitation in Vulnerable Patients Undergoing Cystectomy for Bladder Cancer

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01840137
Enrollment
53
Registered
2013-04-25
Start date
2012-06-30
Completion date
2019-04-30
Last updated
2019-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder Cancer

Brief summary

The development of clinically relevant and scalable exercise interventions in older cystectomy patients may have an impact upon: * Patients: Exercise interventions may improve patient outcomes, including quality of life and avoidance of skilled nursing facilities. * Clinicians: Proving the safety and feasibility of targeted interventions in older surgical patients may facilitate the development of clinically relevant preoperative interventions suitable for wider study and implementation. * Payers: Improved surgical outcomes among high risk surgical patients will be associated with significant cost savings. * Researchers: Targeted and well controlled studies focusing on improving surgical outcomes through exercise may provide insight into relationships between patient factors, surgical stressors and outcomes. Ultimately, such work may lead to novel clinical approaches to optimize patients for surgery. The investigators will study the effects of preoperative exercise training on cystectomy patients, specifically targeting increasing functional capacity and muscular strength. Prior to conducting a more extensive, multi-center, randomized-controlled trial, the feasibility, safety, and initial efficacy of preoperative exercise in cystectomy patients must be determined. To address this issue, the investigators will complete a trial of rehabilitation in cystectomy patients at the University of Michigan.

Interventions

OTHERBaseline Strength Test

A symptom limited submaximal cardiopulmonary exercise test to estimate the subject's exercise capacity.

OTHERExercise

Treadmill and muscle exercises.

Sponsors

University of Michigan
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients must have biopsy-proven bladder cancer. * Patients age ≥60, diagnosed with bladder cancer with planned cystectomy and urinary diversion, +/- neoadjuvant chemotherapy. * The patient must be able to communicate and understand/complete forms/instructions, and be able to provide informed written consent prior to enrollment. Patients may have the assistance of an interpreter or surrogate when completing forms/surveys as needed. * Karnofsky performance status ≥70 with the ability to walk unassisted. * Sedentary baseline lifestyle, with an average of \<180 minutes/week of moderate-intensity aerobic activity. * Attending surgeon clearance to undergo a supervised exercise training program.

Exclusion criteria

* Contraindication to exercise training, such as skeletal metastases, symptomatic coronary artery disease, severe anemia, or any condition limiting their ability to participate in an exercise training program. * Patients who require surgery sooner than 28 days from enrollment.

Design outcomes

Primary

MeasureTime frameDescription
Assess whether a pre-operative exercise training program (Prehabilitation) for elderly patients undergoing cystectomy for bladder cancer will lower their post-operative 90-day hospital readmission rate.3 YearsThe study will compare the readmission rate of 70 recruited prehabilitation patients to the historic readmission rates from our institution and the published literature. Readmission will be defined as an admission to any acute care hospital after initial discharge from the immediate post-operative stay within 90 days of surgery. Visits to emergency rooms or urgent, unscheduled outpatient evaluations will be tracked, but will not count as a readmission. We will also track instances in which patients experience multiple re-admissions within 90 days of surgery, but for the purposes of this study, multiple re-admissions for an individual patient will only count as a single readmission event.

Secondary

MeasureTime frameDescription
Determine the efficacy of prehabilitation on improving functional capacity and strength from baseline levels.3 YearsA submaximal exercise test and 6 minute walk test will be used to assess the maximal rate of oxygen utilization and functional capacity at baseline and at the conclusion of the intervention period. Muscular strength will be evaluated using volume loading.
Composite of measures assessing the effects of prehabilitation on peri-operative cystectomy complications, resource utilization, patient reported outcomes, and functional status.3 yearsEarly (within 30 days of surgery) and late (between 31 and 90 days of surgery) complications, length of hospital stay, resource utilization (emergency room visits, need for sub-acute rehabilitation or nursing home stays, and the costs associated with this additional care) and post-operative outcomes, such as functional capacity and quality of life, will be evaluated and compared to historic data available in the published literature.
Evaluate safety for a prehabilitation program in elderly cystectomy patients.3 YearsThe endpoint for safety is the prevalence of adverse events during study-related assessments and exercise training sessions.
Rates of attrition for a prehabilitation program in elderly cystectomy patients.3 YearsStudy attrition will be the rate at which patients drop out of the study.
Rates of adherence for a prehabilitation program in elderly cystectomy patients.3 YearsStudy adherence will be the percentage of prescribed exercise sessions each participant completes during the treatment period.
Rates of accrual for a prehabilitation program in elderly cystectomy patients.3 YearsTrack the study recruitment rate and, once patients have been screened by the study team and approached to participate, note the reasons that patients who choose not to participate give for their refusal (personal preference, medical comorbidities/deconditioning, perceived program intensity, time commitment for the study protocol, travel distance or lack of consistent means of travel).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026